Features

  • Full Receptor Binding Domain (RBD) presented to immune system
  • Glycosylated Fc activates immune system response
  • Clinical studies show robust, neutralizing antibody production
  • Designed to induce and/or augment antibody titers in patients
  • Production uses established, high-volume methods
  • Effective at microgram doses